Journal of Medicinal Chemistry · 2002 · 14 citations · 12 references
Life SciencesBiochemistryChemistryIron Metabolism DisordersMetabolismRedox BiochemistryBioinorganic ChemistryChelation TherapyIron Chelation TherapyIron HomeostasisIron MetabolismReactive Oxygen SpeciesBiological CharacterizationIron BiochemistryIron Overload PathophysiologyIron Overload SyndromesIron Redox ChemistryIron-dependent Lipid PeroxidationPhysicochemical PropertiesPhysicochemical Property Analysis
Increasing evidence suggests that iron plays an important role in tissue damage both during chronic iron overload diseases (i.e., hemochromatosis) and when, in the absence of actual tissue iron overload, iron is delocalized from specific carriers or intracellular sites (inflammation, neurodegenerative diseases, postischaemic reperfusion, xenobiotic intoxications, etc.). In the present work, we appropriately modified an iron chelator of the hydroxychromene family in order to obtain a tridentate chelator that would inactivate the iron redox cycle after its complexation, with a view to using this molecule in human therapy and/or in disease prevention. We synthesized such a chelator for the first time and show, by different physicochemical analysis, its tridentate nature and, importantly, its capacity to chelate iron with enough strength to inhibit both iron-dependent H(2)O(2) generation and lipid peroxidation in in vitro biological systems.
12
Iron-Chelating Therapy and the Treatment of Thalassemia
Nancy F. Olivieri, Gary M. Brittenham · Blood · 1997 · 1.1K citations · Full text
Ann Evers, Robert D. Hancock, Arthur E. Martell et al. · Inorganic Chemistry · 1989 · 282 citations
Metal Ions in Biological Systems
J. Koryta · Journal of Electroanalytical Chemistry · 1985 · 260 citations